-
ArcticDx, Inc. et al v. Sequenom, Inc. et al DC
- 2:12-cv-00081
- E.D. Tex.
- Judge: Rodney Gilstrap
+1
- Filed: 02/29/2012
- Closed: 11/16/2012
- Latest Docket Entry: 11/16/2012
- PACER
- Docket updated daily
3
Plaintiffs
2
Defendants
1
Accused
Product
6
Patents-in-Suit
262
Days in
Litigation
-
ArcticDx, Inc. et al v. Sequenom, Inc. et al DC
- 2:12-cv-00081
- E.D. Tex.
- Judge: Rodney Gilstrap
+1
- Filed: 02/29/2012
- Closed: 11/16/2012
- Latest Docket Entry: 11/16/2012
- PACER
- Docket updated daily
Causes of Action
Willful Patent Infringement
Declaratory Judgment
Patent Invalidity
Patent Non-Infringement
Patent Non-Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
ArcticAx Incorporated
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Macula Risk product | US 7,351,524 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,695,909 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,867,727 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,053,190 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,088,579 B2 | All Asserted Claims |
No infringement
Entry 40
|
ArcticAx US Limited
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Macula Risk product | US 7,351,524 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,695,909 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,867,727 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,053,190 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,088,579 B2 | All Asserted Claims |
No infringement
Entry 40
|
ArcticDx Incorporated
- 5 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Macula Risk product | US 7,351,524 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,695,909 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 7,867,727 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,053,190 B2 | All Asserted Claims |
No infringement
Entry 40
|
| Macula Risk product | US 8,088,579 B2 | All Asserted Claims |
No infringement
Entry 40
|
